A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.

作者信息

FREIS E D, PARTENOPE E A, LILIENFIELD L S, ROSE J C

出版信息

Circulation. 1954 Apr;9(4):540-6. doi: 10.1161/01.cir.9.4.540.

DOI:10.1161/01.cir.9.4.540

PMID:13150518

Abstract

摘要

相似文献

A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.

Circulation. 1954 Apr;9(4):540-6. doi: 10.1161/01.cir.9.4.540.

Action of ecolid in man.

Br Med J. 1956 Feb 11;1(4962):319-22. doi: 10.1136/bmj.1.4962.319.

Treatment of hypertension with pentolinium and mecamylamine.

Br Med J. 1959 Feb 21;1(5120):462-5. doi: 10.1136/bmj.1.5120.462.

Drug treatment of hypertension.

Pharmacol Rev. 1953 Jun;5(2):135-74.

[Treatment of arterial hypertension with M & B 2050A (pentapyrrolidinium bitartrate)].

Arch Hosp Univ. 1955 Mar-Apr;7(2):113-9.

The drug treatment of severe hypertensive disease, with particular reference to hydralazine and pentapyrrolidinium.

Trans Am Coll Cardiol. 1955 Dec;5:101-6.

[Clinical use of pentapyrrolidinium (M & B 2050 A) combined with Rauwolfia serpentina in the treatment of arterial hypertension].

Rev Med Cubana. 1955 Oct;66(10):741-9.

[Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].

Belg Tijdschr Geneesk. 1955 Aug 1;11(15):759-67.

Effect of hypotensive drugs on renal function in chronic renal disease.

Lancet. 1957 Jan 12;272(6959):68-74. doi: 10.1016/s0140-6736(57)90254-4.

[Therapy of hypertension by the ganglion blocking agents, oxaditon & ansolysen].

Ugeskr Laeger. 1957 Oct 3;119(40):1310-3.

引用本文的文献

Significant clinical variations in hypertension.

J Natl Med Assoc. 1955 Jul;47(4):232-8.

The actions of heterocyclic bisquaternary compounds, especially of a pyrrolidinium series.

Br J Pharmacol Chemother. 1955 Mar;10(1):124-32. doi: 10.1111/j.1476-5381.1955.tb00070.x.

[Clinical studies on the deblocking properties of prostigmine in ganglion blockade induced by ecolid and pendiomide].

Klin Wochenschr. 1957 Nov 15;35(22):1133-9. doi: 10.1007/BF01489420.

Experience in the treatment of hypertension with pentapyrrolidinium (ansolysen) in a hypertension outpatient clinic.

Can Med Assoc J. 1957 Aug 15;77(4):325-8.

The hypotensive action of mercamylamine.

Br Med J. 1956 Nov 24;2(5003):1209-11. doi: 10.1136/bmj.2.5003.1209.

Ansolysen in the treatment of arterial hypertension.

Can Med Assoc J. 1956 May 15;74(10):802-7.

[New drugs for the management of hypertension].

Klin Wochenschr. 1956 Jan 15;34(3-4):57-61. doi: 10.1007/BF01467160.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验